576 related articles for article (PubMed ID: 15293901)
21. Diagnosis of Clostridium difficile-associated intestinal disease.
Rolfe RD
Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
[TBL] [Abstract][Full Text] [Related]
22. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.
Snell H; Ramos M; Longo S; John M; Hussain Z
J Clin Microbiol; 2004 Oct; 42(10):4863-5. PubMed ID: 15472364
[TBL] [Abstract][Full Text] [Related]
23. Clostridium difficile infection in patients with ileal pouch-anal anastomosis.
Shen BO; Jiang ZD; Fazio VW; Remzi FH; Rodriguez L; Bennett AE; Lopez R; Queener E; Dupont HL
Clin Gastroenterol Hepatol; 2008 Jul; 6(7):782-8. PubMed ID: 18467184
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
[TBL] [Abstract][Full Text] [Related]
25. Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.
Akerlund T; Svenungsson B; Lagergren A; Burman LG
J Clin Microbiol; 2006 Feb; 44(2):353-8. PubMed ID: 16455883
[TBL] [Abstract][Full Text] [Related]
26. Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.
Markowitz JE; Brown KA; Mamula P; Drott HR; Piccoli DA; Baldassano RN
Am J Gastroenterol; 2001 Sep; 96(9):2688-90. PubMed ID: 11569696
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
[TBL] [Abstract][Full Text] [Related]
28. [Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].
Jakobsen L; Tvede M
Ugeskr Laeger; 2006 Apr; 168(17):1634-5. PubMed ID: 16674873
[TBL] [Abstract][Full Text] [Related]
29. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.
Lozniewski A; Rabaud C; Dotto E; Weber M; Mory F
J Clin Microbiol; 2001 May; 39(5):1996-8. PubMed ID: 11326033
[TBL] [Abstract][Full Text] [Related]
30. Importance of culture for detection of Clostridium difficile toxin from stool samples to report true incidence and mortality related to C. difficile in hospitals.
Bayardelle P
Clin Infect Dis; 2009 Oct; 49(7):1134-5; author reply 1135. PubMed ID: 19739961
[No Abstract] [Full Text] [Related]
31. Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents.
Nomura K; Fujimoto Y; Yamashita M; Morimoto Y; Ohshiro M; Sato K; Oyake T; Kowata S; Konishi H; Yoshikawa T; Ishida Y; Taniwaki M;
Scand J Gastroenterol; 2009; 44(1):74-8. PubMed ID: 18781540
[TBL] [Abstract][Full Text] [Related]
32. Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea.
Vaishnavi C; Thapa BR; Thennarasu K; Singh K
Indian J Pathol Microbiol; 2002 Jan; 45(1):69-73. PubMed ID: 12593568
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the premier toxin A and B assay and the TOX A/B II assay for diagnosis of Clostridium difficile infection.
Novak-Weekley SM; Hollingsworth MH
Clin Vaccine Immunol; 2008 Mar; 15(3):575-8. PubMed ID: 18175802
[TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile and its cytotoxin in diarrhoeic stools of hospitalized patients. Toxigenic potential of the isolates.
De Barbeyrac B; Guinet R; Quentin C; Cantet P; Bebear C
Ann Biol Clin (Paris); 1989; 47(2):67-70. PubMed ID: 2660635
[TBL] [Abstract][Full Text] [Related]
35. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.
Bauer MP; Veenendaal D; Verhoef L; Bloembergen P; van Dissel JT; Kuijper EJ
Clin Microbiol Infect; 2009 Dec; 15(12):1087-92. PubMed ID: 19624512
[TBL] [Abstract][Full Text] [Related]
36. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
[TBL] [Abstract][Full Text] [Related]
38. [The value of rectosigmoidoscopy and the bacteriologic culture of colon biopsies in the etiologic diagnosis of acute diarrhea of adults. A prospective study of 65 patients].
Bellaiche G; Le Pennec MP; Slama JL; Ley G; Choudat L; Giacomini T; Godefroy Y; Paugam B
Ann Gastroenterol Hepatol (Paris); 1996; 32(1):11-7. PubMed ID: 8669803
[TBL] [Abstract][Full Text] [Related]
39. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
40. Which specimens should be tested for Clostridium difficile toxin?
Berrington A; Settle CD
J Hosp Infect; 2007 Mar; 65(3):280-2. PubMed ID: 17275962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
